Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
(VOVWORLD) -Novavax’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.
 (Photo: Reuters) |
The vaccine was also about 86% effective in protecting against the more contagious virus variant first discovered and now prevalent in the UK.
It was about 90% effective overall, combining data from people infected with both versions of the coronavirus.
If authorized, it would follow three COVID-19 vaccines previously approved for use in Britain from Pfizer and partner BioNTech, Moderna and the AstraZeneca shot developed with Oxford University.